Month: <span>November 2023</span>

Home / 2023 / November
From soft tissue to stiff leather: Understanding the role of paxillin in liver fibrosis
Post

From soft tissue to stiff leather: Understanding the role of paxillin in liver fibrosis

by Medical University of South Carolina Paxillin localization during HSC activation. (A) HSCs were isolated, grown on glass coverslips for 7 days, and fixed. Paxillin was labeled at the specified time points as described in the Materials and Methods. DAPI was used to label nuclei. The boxes in row 3 of the panel illustrate magnified area in...

Alternative antibiotic selection can reduce the risk of health care-associated infections for patients with pneumonia
Post

Alternative antibiotic selection can reduce the risk of health care-associated infections for patients with pneumonia

by Association for Professionals in Infection Control Credit: Unsplash/CC0 Public Domain A new study published today in the American Journal of Infection Control (AJIC) reveals that the use of doxycycline may help protect against Clostridioides difficile (C. diff) infection for some patients with pneumonia. Specifically, study authors found that for hospitalized patients with community-acquired pneumonia...

‘Super melanin’ heals skin injuries from sunburn, chemical burns
Post

‘Super melanin’ heals skin injuries from sunburn, chemical burns

by Northwestern University The synthetic melanin is being applied to inflamed skin. Just under the surface of the skin are green free radicals, also known as ROS, or “reactive oxygen species.” Credit: Yu Chen, Northwestern University Imagine a skin cream that heals damage occurring throughout the day when your skin is exposed to sunlight or environmental...

FDA advisors say new gene therapy for sickle cell disease is safe
Post

FDA advisors say new gene therapy for sickle cell disease is safe

by Physician’s Briefing Staff A new gene therapy for sickle cell disease has been deemed safe by a U.S. Food and Drug Administration advisory panel, paving the way for full approval by early December 2023. The FDA had already decided that the therapy, known as exagamglogene autotemcel (exa-cel), was effective. Developed by Vertex Pharmaceuticals of...

‘Lab on a chip’ genetic test device can identify viruses within three minutes with top-level accuracy
Post

‘Lab on a chip’ genetic test device can identify viruses within three minutes with top-level accuracy

by University of Bath Dr Despina Moschou with LoCKAmp replaceable lab on chip printed circuit board. Credit: University of Bath A virus diagnosis device that gives lab-quality results within just three minutes has been invented by engineers at the University of Bath, who describe it as the “world’s fastest COVID test.” The prototype LoCKAmp device uses...

Dysfunction of mitochondria drives the exhaustion of T cells, study shows
Post

Dysfunction of mitochondria drives the exhaustion of T cells, study shows

by Julius-Maximilians-Universität Würzburg a Adoptive co-transfer of WT (tdTomato+GFP+) and HIF-1α-deficient (tdTomato+) P14 T cells into C57BL/6 mice before chronic infection with LCMV clone 13 (LCMVCL13). 21 days post infection (d.p.i.), donor P14 WT and HIF-1α-deficient T cells were FACS sorted, barcoded, and multiplexed in a 1:1 ratio and subjected to single-cell RNA sequencing. Uniform manifold...

A ‘manganese bullet’ targeting cardiovascular disease? Research finds potential therapy for intensive lipid lowering
Post

A ‘manganese bullet’ targeting cardiovascular disease? Research finds potential therapy for intensive lipid lowering

by Higher Education Press Manganese therapy enables the reversal of atherosclerotic plaque. Credit: Yawei Wang, Xin Feng, Wenjing Zhou, Runze Huang, Yating Hu, Hui Hui, Jie Tian, Xiao Wang, Xiao-Wei Chen Cardiovascular disease (CVD) continue to rank as the top killer in the modern world. This deadly disorder often starts with the buildup of lipid...

Study provides preliminary evidence in favor of a new type 1 diabetes treatment
Post

Study provides preliminary evidence in favor of a new type 1 diabetes treatment

by University of Chicago Medical Center Credit: Cell Reports Medicine (2023). DOI: 10.1016/j.xcrm.2023.101261 Type 1 diabetes is an autoimmune disease that causes the body’s immune system to attack and destroy insulin-producing beta cells in the pancreas. Traditional management of type 1 diabetes has primarily involved replacing the missing insulin with injections which, though effective, can be...

Novel approach promises significant advance in treating autoimmune brain inflammation
Post

Novel approach promises significant advance in treating autoimmune brain inflammation

by Marcus Neitzert, Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) Credit: Cell (2023). DOI: 10.1016/j.cell.2023.10.001 Researchers at DZNE and Charité–Universitätsmedizin Berlin have pioneered a novel treatment for the most common autoimmune encephalitis. By reprogramming white blood cells to target and eliminate disease-causing cells, the approach offers a new level of precision and efficiency. The technique...